This inventor holds 28 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents, primarily in Vaccine Development. Top assignees: Corixa Corporation, Immunex Corporation, Sterling Winthrop Inc.. Active years: 1995-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Winslow, WA (US) (1995)
- Bainbridge, WA (US) (2005 - 2008)
- Bainbridge Island, WA (US) (1997 - 2017)
Company Filing History:
15 out of 247 
9 out of 451 
2 out of 206 
Years Active: 1995-2017
Areas of Expertise:
Title: **Mark R Alderson: Innovator in Immunogenic Vaccine Development**
Introduction
Mark R Alderson is a prominent inventor based in Bainbridge Island, Washington. He holds an impressive portfolio of 28 patents, showcasing his significant contributions to the field of immunology and vaccine development. His innovative work has focused on the creation of advanced immunogenic compositions aimed at enhancing disease prevention methods.
Latest Patents
Among his latest patents, Alderson developed a selectively disrupted whole-cell vaccine. This invention entails immunogenic compositions and methods for producing such compositions with various immunity-inducing fractions from killed, whole-cell bacterial preparations. By selectively disrupting these whole cells, the resulting immunogenic composition can include a soluble fraction that primarily induces an antibody response as well as a cellular fraction leading to an antibody-independent response.
Another notable patent concerns vaccines against chlamydial infections. This inventive concept comprises proteins or polynucleotides specific to certain strains, highlighting combinations of these proteins or polynucleotides and methods for their use in treating, preventing, and diagnosing infections.
Career Highlights
Alderson's career is marked by his tenure at reputable companies in the biotechnology sector. He has worked with Corixa Corporation and Immunex Corporation, where he played a crucial role in vaccine research and development. His expertise in immunology has significantly influenced vaccine formulations and strategies.
Collaborations
Throughout his career, Alderson has collaborated with distinguished colleagues, including Yasir A Skeiky and Steven G Reed. These partnerships have likely fostered an environment of innovation, facilitating advancements in immunogenic research and the development of groundbreaking vaccines.
Conclusion
Mark R Alderson's journey as an inventor reflects a deep commitment to improving public health through innovative vaccine technologies. His patents exemplify a blend of scientific creativity and practical application, positioning him as a key contributor to the future of immunotherapeutics. His ongoing work continues to inspire advancements in the field, promising broader protective solutions against infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile